1,853 material Form 8-K filings that 1,500 companies we cover made with the SEC in September 2026, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Intelligent Bio Solutions said it submitted a 510(k) premarket notification to the FDA seeking clearance of its Intelligent Fingerprinting Drug Screening System for detecting codeine. The company says the submission is based on a 2026 clinical program and that FDA clearance is expected to expand its addressable U.S. market beyond forensic-use-only settings. The filing does not state a clearance timeline or any financial figures.
Submission announced September 9, 2026 for codeine detection on the Intelligent Fingerprinting Drug Screening System
Method Comparison Study reported accuracy above 98%, sensitivity above 94% and 100% specificity across three U.S. clinical sites
Cybersecurity review reported 100% of medium-risk vulnerabilities remediated and all 19 SBOM vulnerabilities resolved
Filing gives no FDA review timeline and no financial results or guidance
Definitive Healthcare disclosed that representatives of its tax receivable agreement (TRA) holders have irrevocably waived the right to an Early Termination Payment tied to any change of control with a definitive merger agreement signed on or before December 31, 2026. The TRA will terminate upon consummation of such a qualifying change of control, while TRA holders keep their other rights, including tax benefit payments for prior and current years.
Waiver covers change-of-control transactions with a definitive merger agreement executed on or before December 31, 2026.
Upon consummation of a qualifying change of control, the TRA terminates under its terms.
TRA holders keep rights to tax benefit payments for taxable years ending before, with, or including the transaction.
The company says it is not a party to the waiver; the filing gives no dollar amounts.
GameSquare Holdings received a Nasdaq letter on September 8, 2026 confirming it has regained compliance with the $1.00 minimum bid price requirement for continued listing on The Nasdaq Capital Market. Nasdaq has closed the matter, removing the bid price deficiency that had been disclosed in September 2025.
Nasdaq notified the company of a bid price deficiency on September 10, 2025, after 30 consecutive trading days below $1.00 per share.
Compliance was regained because the closing bid price was at or above $1.00 for 10 consecutive business days, from August 24, 2026 to September 4, 2026.
Nasdaq considers the matter closed; the filing was signed by CEO Justin Kenna on September 9, 2026.
Nasdaq granted Iveda Solutions an additional 180 calendar days, until March 1, 2027, to regain compliance with its $1.00 minimum bid price rule, after the company requested the extension on September 2, 2026. The extension delays a possible delisting, but the stock must still close at or above $1.00 for at least 10 consecutive business days, and the company has not decided on a reverse stock split.
Nasdaq first notified Iveda on March 6, 2026, that its closing bid price had been below $1.00 for 30 consecutive business days.
Iveda received the second grace period letter from Nasdaq on September 4, 2026, extending the deadline to March 1, 2027.
Iveda may consider a reverse stock split if appropriate, but has not announced a decision to implement one.
The company may still be delisted during the period if it fails other Nasdaq listing requirements, and Nasdaq would issue a delisting notice if compliance is not shown by March 1, 2027.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.